Profile data is unavailable for this security.
About the company
Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
- Revenue in USD (TTM)176.67m
- Net income in USD18.72m
- Incorporated1996
- Employees712.00
- LocationAtrion CorpOne Allentown ParkwayALLEN 75002United StatesUSA
- Phone+1 (972) 390-9800
- Fax+1 (302) 655-5049
- Websitehttps://atrioncorp.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nano-X Imaging Ltd | 9.91m | -60.78m | 563.44m | 164.00 | -- | 2.88 | -- | 56.88 | -1.08 | -1.08 | 0.1757 | 3.38 | 0.0419 | -- | 8.05 | 60,396.34 | -25.72 | -30.98 | -28.14 | -35.10 | -66.55 | -- | -613.59 | -1,527.24 | 5.56 | -- | 0.0175 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Orthofix Medical Inc | 760.05m | -126.48m | 566.69m | 1.63k | -- | 0.9905 | -- | 0.7456 | -3.40 | -3.40 | 20.42 | 15.24 | 0.8338 | 1.16 | 6.36 | 465,143.80 | -13.87 | -8.88 | -16.48 | -10.96 | 66.20 | 72.37 | -16.64 | -9.28 | 1.19 | -8.38 | 0.194 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| SI-Bone Inc | 144.05m | -43.12m | 593.35m | 344.00 | -- | 3.57 | -- | 4.12 | -1.08 | -1.08 | 3.61 | 4.03 | 0.7728 | 1.62 | 6.44 | 418,735.50 | -23.13 | -27.88 | -25.72 | -30.94 | 78.10 | 85.03 | -29.93 | -51.09 | 8.75 | -- | 0.1791 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Varex Imaging Corp | 855.80m | 41.90m | 613.91m | 2.30k | 24.85 | 1.06 | 7.97 | 0.7174 | 0.604 | 0.604 | 16.18 | 14.10 | 0.7008 | 1.94 | 5.50 | 356,583.30 | 3.47 | 0.9913 | 4.03 | 1.18 | 32.39 | 31.70 | 4.95 | 1.36 | 2.37 | 2.57 | 0.4292 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
| Paragon 28 Inc | 225.44m | -54.02m | 621.31m | 430.00 | -- | 3.78 | -- | 2.76 | -0.6536 | -0.6536 | 2.73 | 1.98 | 0.6956 | 0.5405 | 5.82 | 524,267.40 | -16.67 | -- | -20.52 | -- | 79.21 | -- | -23.96 | -- | 1.78 | -6.45 | 0.4018 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Fulgent Genetics Inc | 287.53m | -165.95m | 650.55m | 1.18k | -- | 0.5751 | -- | 2.26 | -5.57 | -5.57 | 9.64 | 37.80 | 0.2206 | -- | 6.01 | 242,846.30 | -13.29 | 16.70 | -14.16 | 18.37 | 37.47 | 67.89 | -60.25 | 29.06 | -- | -- | 0.0014 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
| Orthopediatrics Corp | 161.83m | -21.97m | 775.15m | 247.00 | -- | 2.07 | -- | 4.79 | -0.9647 | -0.9647 | 7.11 | 15.74 | 0.3748 | 0.4247 | 5.13 | 655,178.10 | -5.09 | -5.40 | -5.62 | -5.93 | 74.07 | 75.09 | -13.58 | -15.92 | 1.99 | -- | 0.0271 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| Cytek Biosciences Inc | 200.79m | -11.51m | 782.39m | 637.00 | -- | 1.99 | -- | 3.90 | -0.0856 | -0.0856 | 1.50 | 2.99 | 0.395 | 1.44 | 4.30 | 297,020.70 | -2.26 | -- | -2.54 | -- | 55.48 | -- | -5.73 | -- | 6.01 | -- | 0.0086 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| Embecta Corp | 1.13bn | 70.20m | 803.35m | 2.20k | 11.45 | -- | 7.59 | 0.7094 | 1.22 | 1.22 | 19.62 | -13.35 | 0.94 | 2.51 | 15.86 | 514,772.70 | 5.83 | -- | 8.06 | -- | 65.57 | -- | 6.20 | -- | 1.79 | 1.51 | 1.89 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Atrion Corp | 176.67m | 18.72m | 831.40m | 712.00 | 44.42 | 3.44 | 24.27 | 4.71 | 10.63 | 10.63 | 100.32 | 137.46 | 0.6794 | 1.56 | 7.93 | 248,127.80 | 7.20 | 11.96 | 7.63 | 12.62 | 33.77 | 41.99 | 10.60 | 19.05 | 3.06 | -- | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
| Silk Road Medical Inc | 185.49m | -53.42m | 896.95m | 474.00 | -- | 6.09 | -- | 4.84 | -1.37 | -1.37 | 4.76 | 3.73 | 0.7247 | 2.08 | 7.87 | 391,322.80 | -20.87 | -29.02 | -22.75 | -32.98 | 73.31 | 72.91 | -28.80 | -46.84 | 9.62 | -- | 0.34 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
| Avanos Medical Inc | 680.10m | -1.60m | 932.77m | 3.77k | -- | 0.7623 | 21.30 | 1.37 | -0.0315 | -1.33 | 14.62 | 26.65 | 0.4005 | 1.62 | 5.48 | 180,350.00 | -0.0942 | -0.6527 | -0.1055 | -0.7338 | 56.33 | 54.45 | -0.2353 | -1.60 | 1.47 | 4.85 | 0.1257 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Artivion Inc | 368.21m | -9.58m | 993.70m | 1.50k | -- | 3.37 | 72.93 | 2.70 | -0.2615 | -0.2615 | 8.64 | 7.07 | 0.4779 | 1.64 | 5.37 | 245,470.70 | -1.25 | -2.20 | -1.33 | -2.36 | 64.75 | 65.51 | -2.61 | -5.34 | 4.26 | 2.26 | 0.5176 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| BioLife Solutions Inc | 137.30m | -62.93m | 1.00bn | 409.00 | -- | 2.99 | -- | 7.32 | -1.43 | -1.43 | 3.10 | 7.30 | 0.3238 | 2.17 | 5.61 | 335,687.00 | -14.84 | -13.76 | -16.52 | -15.04 | 32.97 | 36.76 | -45.84 | -42.99 | 1.77 | -32.08 | 0.0717 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| AtriCure Inc | 414.60m | -37.23m | 1.08bn | 1.20k | -- | 2.37 | -- | 2.60 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -10.27 | 0.1212 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
Data as of May 21 2024. Currency figures normalised to Atrion Corp's reporting currency: US Dollar USD
51.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kayne Anderson Rudnick Investment Management LLCas of 31 Mar 2024 | 203.28k | 11.55% |
| Neuberger Berman Investment Advisers LLCas of 31 Mar 2024 | 179.10k | 10.18% |
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 138.75k | 7.88% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 89.87k | 5.11% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 81.17k | 4.61% |
| Atlanta Capital Management Co. LLCas of 31 Mar 2024 | 53.28k | 3.03% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 47.40k | 2.69% |
| D. F. Dent & Co., Inc.as of 31 Mar 2024 | 42.94k | 2.44% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 37.22k | 2.12% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 37.21k | 2.11% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
